Is IBEX Limited (IBEX) Overvalued?
We dive into why IBEX Limited (IBEX) could be considered overvalued on 2026-08-14, based on AAII’s Value Score and Grade.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Rosalio Madrigal
Rosalio Madrigal
Rosalio Madrigal
Jenna Brashear
| Share Statistics | IBEX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $478.9 | $1,141.8 | 36% |
|
| Shares Out (Mil) | 15.0 | 39.0 | 25% |
|
| Institutional Ownership | 93.5% | 87.3% | 63% |
|
| Float (Mil) | 10.9 | 34.7 | 20% |
|
| Beta | 0.65 | 0.77 | 38% |
|
| Avg Daily Volume (000s) | 126 | 452 | 38% |
|
| Price Change (52-week) |
22.9% | 70.7% | 63% |
|
| Growth | IBEX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 6.6% | 7.4% | 43% |
|
| Net Income (5yr) | 36.5% | 8.0% | 89% |
|
| EPS (5yr) | 31.4% | 11.8% | 82 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (18.0%) | (13.8%) | 38% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | $0.845 | $3.520 | $3.625 | |
| Month Ago EPS | $0.845 | $3.520 | $3.625 | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 1 | 1 | 0 | |
| Three Months Ago EPS | $0.845 | $3.520 | $3.625 | |
| Year/Year Chg | (5.1%) | 49.4% | 74.0% | |
| Financials | IBEX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $627 | $1,344 | 44% |
|
| Net Income (TTM) (Mil) | $47 | $37 | 54% |
|
| EPS (TTM) | $3.517 | $0.800 | 80% |
|
| Operating Cash Flow (TTM) (Mil) | $62 | $153 | 48% |
|
| Net Cash Flow (TTM) (Mil) | $2 | $0 | 49% |
|
| Long-Term Debt (Q1) (Mil) | $46 | $214 | 39% |
|
| Enterprise Value (Q1) (Mil) | $479 | $1,701 | 33% |
|
| Valuation | IBEX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.99 | 2.81 | 64% |
|
| P/E | 11.2 | 23.8 | 21% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.4 | 1.2 | 16% |
|
| Ratios | IBEX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 29.9% | 36.5% | 35% |
|
| Net Margin | 7.5% | 3.2% | 56% |
|
| ROA | 16.5% | 3.1% | 94% |
|
| ROE | 33.1% | 8.4% | 89% |
|
| Liabilities to Assets | 45.9% | 59.0% | 37% |
|
| F-Score | 7 | 5 | 82% |
|
Passing Stock Screens
As of 8/19/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 13.9% |
| +/- S&P 500: | +6.4 |
| Performance Since Inception: | 12.1% |
| +/- S&P 500: | +4.6 |
| Performance Since Inception: | 11.4% |
| +/- S&P 500: | +3.9 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors